Health News4 years ago
FDA Approves Enspryng (satralizumab-mwge) for Neuromyelitis Optica Spectrum Disorder
FDA Approves Enspryng (satralizumab-mwge) for Neuromyelitis Optica Spectrum Disorder Print this page South San Francisco, CA — August 14, 2020 — Genentech, a member of the...